Canaccord Genuity Maintains Buy on Guardant Health, Lowers Price Target to $30

Guardant Health -3.78%

Guardant Health

GH

32.55

-3.78%

Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ: GH) with a Buy and lowers the price target from $45 to $30.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via